Profile

Leslie Renee Ellis, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

103 Ratings
17 Comments
 

Leslie Renee Ellis, M.D.

Associate Professor,


Clinical Interests

Acute and Chronic Leukemia, Chronic Leukemias, Hematologic Malignancies, Leukemia

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.S., Duke University, 1991
  • M.D., University of North Carolina-Chapel Hill, 2000
  • Internship, Internal Medicine, Univ Hosp (U Of Michigan), 2001
  • Residency, Internal Medicine, U Michigan Affil Hosps, 2003
  • Fellowship, Hematology And Oncology, Cornell University, 2006

NPI Number

  • 1790861128
Leslie Renee Ellis, M.D.

Doctor Rating

4.7 out of 5

103 Ratings
17 Comments
 

Leslie Renee Ellis, M.D.

Associate Professor, Hematology & Oncology
Comprehensive Cancer Center
Office of Women in Medicine and Science

Research Interests

cancer/oncogenesis, drugs/therapeutic agents pharm

Contact Information

Academic: 336-716-4759 | Department: 336-716-4464

Recent Publications

Ahmed T, Holwerda S, Klepin HD, Isom S, Ellis LR, Lyerly S, Manuel M, Dralle S, Berenzon D, Powell BL, Pardee TS. High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly. Leuk Res. 2015;39(9):945-949.

Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Howard DS, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. J Clin Oncol. 2015;33(15 Suppl):7015.

Pardee T, Pladna K, Isom S, Ellis LR, Berenzon D, Howard D, Manuel M, Dralle S, Hurd DD, Lyerly S, Powell BL. The mitochondrial metabolism inhibitor Cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone is highly active in poor risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. Blood. 2015;126(23):2556.

Klepin HD, Tooze J, Pardee T, Ellis LR, Berenzon D, Howard D, Demark-Wahnefried W, Mihalko S, Rejeski WJ, Powell BL, Kritchevsky S. Feasibility of a symptom-adapted physical activity intervention during induction chemotherapy for older adults with acute myeloid leukemia (AML) [abstract]. Blood. 2015;126(23):2102.

Tawfik B, Sliesoraitis S, Lyerly S, Klepin HD, Lawrence J, Isom S, Ellis LR, Manuel M, Dralle S, Berenzon D, Powell BL, Pardee T. Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML). Ann Hematol. 2014;93(1):47-55.

Pardee TS, Lee K, Luddy J, Maturo C, Rodriguez R, Isom S, Miller LD, Stadelman KM, Levitan D, Hurd D, Ellis LR, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies. Clin Cancer Res. 2014;20(20):5255-5264.

Jordan JH, D'Agostino RB Jr, Hamilton CA, Vasu S, Hall ME, Kitzman DW, Thohan V, Lawrence JA, Ellis LR, Lash TL, Hundley WG. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic. Circ Cardiovasc Imaging. 2014;7(6):872-879.

Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Harrelson R, Manuel M, Dralle S, Lyerly S [sic] [Lyerly ES], Powell BL. The mitochondrial metabolism inhibitor Cpi-613 is highly active in combination with high dose Ara-C (HiDAC) and mitoxantrone in a phase I study for relapsed or refractory acute myeloid leukemia (AML). Blood. 2014;124(21):3744.

Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, Ellis LR, Powell BL. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287-4294.

Drafts BC, Twomley KM, D'Agostino R Jr, Lawrence J, Avis N, Ellis LR, Thohan V, Jordan J, Melin SA, Torti FM, Little WC, Hamilton CA, Hundley WG. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877-885.

Bailey J, Currin D, Ellis L, Hite RD. Integrating the caregiver perspective: an interprofessional opportunity [commentary]. Med Educ. 2013;47(11):1137-1138.

Jordan JH, Morgan TM, Ellis LR, Lawrence J, Hall ME, Castellino SM, Hamilton CA, Torti FM, Vasu S, D'Agostino RB, Hundley WG. Pathologic atrophy of the left ventricular myocardium early after receipt of anthracycline-based chemotherapy [abstract]. Circulation. 2013;128(22 Suppl):A17537.

Manny JS, Ellis LR. Acute myeloid leukemia with Charcot-Leyden crystals. Blood. 2012;120(3):503.

Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Ellis LR, Levitan D, Pardee TS, Isom S, Powell BL. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc. 2011;59(10):1837-1846.

Chiou V, Tiegs J, Isom S, Pettenati MJ, Lyerly S, Ellis LR, Pardee T, Dmitriy B, Powell BL, Levitan DA. A single institution analysis of incidence of recurrent chromosomal abnormalities in adult ALL patients according to race, gender, and age [abstract]. Blood. 2011;118(21):4869.

Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J Clin Oncol. 2010;28(1):166-172.

Klepin HD, Tooze JA, Geiger AM, Kritchevsky S, Williamson J, Ellis LR, Levitan D, Pardee T, Isom S, Powell BL. Geriatric assessment predicts overall survival among older adults receiving induction chemotherapy for acute myelogenous leukemia [abstract]. Blood. 2010;116(21):653-654.

Twomley K, D'Agostino R Jr, Lawrence J, Melin S, Ellis LR, Stacey B, Hamilton CA, Torti F, Little W, Hundley W. Early and persistent evidence of subclinical cardiovascular injury after receipt of anthracycline chemotherapy [abstract]. Circulation. 2010;122(21 Suppl):A12766.

Klepin HD, Ellis LR, Levitan D, Powell BL. Feasibility of inpatient geriatric assessment for older adults with acute myelogenous leukemia [abstract]. J Am Geriatr Soc. 2009;57(Suppl 1):S155.

Chaosuwannakit N, D'Agostino R Jr, Hamilton CA, Lane KS, Ntim WO, Lawrence J, Melin SA, Ellis LR, Torti FM, Little WC, Hundley WG. Subclinical cardiovascular toxicity of anthracyclines identified with cardiovascular magnetic resonance imaging [abstract]. Circulation. 2009;120(18 Suppl):S299.

Klepin HD, Geiger AM, Williamson J, Kritchevsky S, Tooze JA, Ellis LR, Levitan D, Isom S, Powell BL. Inpatient geriatric assessment detects impairment among older adults receiving induction chemotherapy for acute myelogenous leukemia [abstract]. Blood. 2009;114(22):570-571.

Powell B, D'Agostino R Jr, Levitan D, Ellis LR, Lyerly S, Skiles M, Manuel M, Harrelson R, Kimbrough C, Hurd DD. High dose cytarabine and clofarabine (HiDAC-->CLOF) in relapsed or refractory acute myeloid leukemia, a phase 2 trial [abstract]. Blood. 2008;112(11):676.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Acute and Chronic Leukemia, Chronic Leukemias, Hematologic Malignancies, Leukemia
Leslie Renee Ellis, M.D.

Leslie Renee Ellis, M.D.

Associate Professor, Hematology & Oncology
Comprehensive Cancer Center
Office of Women in Medicine and Science

Doctor Rating

4.7 out of 5

Leslie Renee Ellis, M.D.103 Ratings
17 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.9
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.9
Wait time at clinic
3.5



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/28/2016

Information and directions always great.

2/21/2016

My providers have always been very accommodating in listening to my concerns. I think I have a great team that is helping me fight this battle. Aside, from the other small issues, I really appreciate all of their help in saving my life.

2/16/2016

Dr Ellis is without a doubt the best; I take great comfort that she is my physician.

2/9/2016

I cannot believe the difference in Dr. Ellis and my previous hematologist at Emory/Winship Cancer Institute. Dr Ellis and her PA provided me with more information (in layman's terms) than I have gleaned in 4.5 years of having CLL.

12/16/2015

I've just started seeing Dr. Ellis, after seeing Dr. Swift more than a year ago I was referred to another Dr. who did not seem to care and was did not give me a comfort level I wanted. When Dr. Hix said I needed to see someone I agreed as long as it wasn't Dr. I had seen earlier. Dr. Ellis knew my history when she walked in and did not need me to tell her things that she could find in my chart. She has been very caring and helpful.

11/24/2015

Excellent.

11/6/2015

*Dr. Ellis is not only a most highly regarded subject-matter expert on my disorder, but she's friendly & easy to talk to. What an exceptional provider she is!

10/21/2015

So thankful for the staff.

9/30/2015

I am so fortunate to have been referred to Dr. Ellis for the management of my condition. She provides exceptional care, involves me in decision making and it is a pleasure to meet with her.

8/21/2015

Caring, compassionate and very professional!

8/12/2015

Very satisfied.

8/3/2015

I have been a patient in Baptist many times - never had a bad experience -

7/31/2015

Seemed very knowledge in her field! Impressed!

7/1/2015

Good.

6/22/2015

The doctor answered all my questions and concerns and took the time to talk to me about the problem I have and made me feel at ease.

6/9/2015

Dr. Ellis is an outstanding clinician but equally important; a very caring person.

5/6/2015

Great personality & warm!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.